phase์ ํซ ๋ด์ค
Warning : Undefined variable $da in
/var/www/hoodb/trend.php on line
250
๋ค์ ์น์ฌ์ดํธ์์ ๋น ๋ฅธ ๊ฒ์ phase .
phase ํค์๋ ๋ค๋ฅธ ์น์ฌ์ดํธ์์๋ ์ต๊ทผ์ phase ์ ๋ํ ํค์๋๋ฅผ ๊ฒ์ํ์ต๋๋ค.
Warning : file_get_contents(aCache/Gkeys/kr/ phase): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
Warning : file_get_contents(aCache/Gkeys/kr/ phase-2): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
phase์ ๋ํ ๋ ๋ง์ ๊ณผ๊ฑฐ ๋ด์ค
Warning : file_get_contents(aCache/aaa/gnews/KR/ phase.xml): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
2024-09-24 11:26
Acurx, ๊ตญ์ Phase 3 CDI ์์์ํ์ ์ํ ibezapolstat ์ค๋น By Investing.com - Investing.com
2024-05-02 07:00
ํ์ด์ฆ Phase: ํผ๊ทธ๋ง์ฒ๋ผ ์ฌ์ด ๋ชจ์
ํด - ๋์์ธ ๋์นจ๋ฐ
2024-09-20 08:28
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 - ํ๋ด์ค
2024-09-13 07:46
GI Innovation submits an application for domestic clinical phase 1/2a of 'GI-108' for metastatic solid cancer - ๋๋ฐ์ด์ค
2024-07-29 09:20
[์ ๋ณด] ๋ชจ์
ํด phase(ํ์ด์ฆ) ์ฅ๋จ์ ๊ณผ ์ฌ์ฉํ๊ธฐ - ๋ธ๋ฐ์น
2024-07-16 07:00
[์์ ๊ตญ๋ดํ์ ๊ต์ ์์ฉ ์ค๋น ๊ณผ์ ] Phase II: ์ง์ ์๋ฅ ์ค๋น - ์๋ฌผํ์ฐ๊ตฌ์ ๋ณด์ผํฐ(BRIC)
2024-07-19 07:00
LG Chem's Aveo faces setback as first kidney cancer combo phase 3 trial fails - ๋ฐ์ด์ค์คํํ
์ดํฐ
2024-07-24 07:00
2024 PLS: PHASE 2 ๋ํ ์๋ด - pubgesports.com
2024-09-22 05:38
Hezbollah, Israel exchange heavy fire in 'new phase' of fighting - XM
2024-04-02 07:00
Government's coal phase-out policy is expected to fail to achieve national carbon neutrality in 2050 - ๊ฒฝํฅ์ ๋ฌธ
2024-09-24 12:58
Assembly Biosciences, Phase 1a ์ฐ๊ตฌ ๊ฒฐ๊ณผ ํ ์ค๋ฆฝ ๋ฑ๊ธ ์ ์ง By Investing.com - Investing.com
2024-08-13 07:00
Lynk Pharmaceuticals Announces Positive Results from Phase 1b Clinical Study of LNK01004 for the Treatment of Atopic Dermatitis - ํ๋ด์ค
2024-09-06 07:00
STCube's 'Nelmastobart' achieves global clinical Phase 1 CSR with 'highest level of safety' - ๋๋ฐ์ด์ค
2024-07-02 07:00
[์์ ๊ตญ๋ดํ์ ๊ต์ ์์ฉ ์ค๋น ๊ณผ์ ] Phase I: CV ์ค๋น - ์๋ฌผํ์ฐ๊ตฌ์ ๋ณด์ผํฐ(BRIC)
2024-06-08 07:00
Phase๋ก ์ ์ํด ๋ณธ ๋ฃจํ ์ ๋๋ฉ์ด์
- ๋ธ๋ฐ์น
2024-08-13 07:00
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial - ํ๋ด์ค
2024-07-30 02:24
[์์ ๊ตญ๋ดํ์ ๊ต์ ์์ฉ ์ค๋น ๊ณผ์ ] Phase III: ๋ฉด์ ๊ณผ ๋ฐํ ์ค๋น - ์๋ฌผํ์ฐ๊ตฌ์ ๋ณด์ผํฐ(BRIC)
2024-07-11 07:00
First Patient Dosed in Phase I Clinical Trial of YOLT-201 - ํ๋ด์ค
2024-08-28 07:00
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization - ํ๋ด์ค
2024-08-23 07:00
CanariaBio Inc Announces Enrollment Completion of randomized Phase 2 study of Oregovomab in combination with chemotherapy as neo-adjuvant treatment of patients with Advanced Ovarian Cancer - ํ๋ด์ค
2024-06-01 07:00
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting - ํ๋ด์ค
2024-08-14 07:00
Celltrion Receives U.S. Phase 3 IND Approval for Cosentyx Biosimilar 'CT-P55' - Korea IT Times
2024-09-19 11:19
Xinhua Headlines: Israel declares "new phase" in conflict with Hezbollah after Lebanon explosions - ๋ค์ดํธ ๋ด์ค
2024-08-27 07:00
ํ์ง ์ํด๋ฆฌ ์๋ฆฌ์ฆ: ํ์ด์ฆ 2 ์๋ด - ๋ด์ค - PUBG: ๋ฐฐํ๊ทธ๋ผ์ด๋ - PUBG: BATTLEGROUNDS
2024-08-28 07:00
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist - ํ๋ด์ค
2024-09-18 17:48
BTIG, Aclaris Therapeutics ์ฃผ์์ ๋ํด ์ค๋ฆฝ์ ์
์ฅ ์ ์ง, Phase 2a ์์์ํ ์์ ์ค By Investing.com - Investing.com
2024-07-30 07:00
Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical Study of BBT-877 for the Treatment of Idiopathic Pulmonary Fibrosis - ํ๋ด์ค
2024-06-12 07:00
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagno - ํ๋ด์ค
2024-07-12 07:00
Turkeyโs Biotech Valley Phase One Complete by 2026, Eyes Korea Partnership - ํํธ๋ด์ค
2024-03-28 07:00
Bio Pharm "Dongsung Pharma Advances 'Phonogen' in Pancreatic Cancer Phase 2 Trial, Photodynamic Therapy Lead" - ํฌ์ค๊ฒฝํฅ
2024-04-18 07:00
TaiGen Successfully Completes TG-1000 Phase III Study - ํ๋ด์ค
2024-09-03 07:00
05ํ ์๊ตญ ์์ด - phonics phase 4 - ๋ธ๋ฐ์น
2024-06-26 07:00
HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002 - ํ๋ด์ค
2024-06-07 07:00
MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease - ํ๋ด์ค
2024-07-29 07:00
Daewoong's Bersiporocin Moves Closer to Market After Phase 2 Safety Approval for IPF - Korea IT Times
2024-09-19 05:02
Roche Says Phase III Results Show Xofluza Significantly Reduces The Transmission Of Influenza Viruses - XM
2024-06-24 07:00
[Koreaโs Blockbuster Vaccine] SK Bioscience โPneumococcus' Vaccine Enters Global Phase 3 - ์ํค๋ฆฌํฌ์คํ๊ตญ
2024-07-05 07:00
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia - ํ๋ด์ค
2024-06-03 07:00
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis - ํ๋ด์ค
2024-03-05 08:00
2024 PWS: PHASE 1 ๋ํ ์๋ด - pubgesports.com
2024-07-12 02:06
Kolon TissueGene completes Phase 3 trial dosing of osteoarthritis drug in U.S. - ๋ค์ดํธ ๋ด์ค
2024-06-10 07:00
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024 - ํ๋ด์ค
2024-01-15 08:00
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia - ํ๋ด์ค
2024-06-04 07:00
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 - ํ๋ด์ค
2024-06-05 07:00
FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC - ํ๋ด์ค
2024-06-07 07:00
์ด์ค์ผ ๊ฒฝํฌ์ฌ์ด๋ฒ๋ ๊ต์ ์์ NUTS, NIST 'SBIR Phase ์ฌ์ด๋ฒ ๋ณด์ ์ฐ๊ตฌ์' ๋ฐ์ - ๋จธ๋ํฌ๋ฐ์ด
2024-09-10 07:00
ํฌ์ค์ฝ, ์ธ๊ณ์ต์ด๋ก '์ ๋ฝํ์ดํผ๋ฃจํ' ์ํ๋
ธ์ ์ ์ ์ฉ๊ฐ์ฌ ๊ณต๊ธ - ๋ด์คํธ๋ฆฌ
2024-04-09 07:00
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib - ํ๋ด์ค
2024-06-18 07:00
ABL Bio's partner company, Compass Therapeutics, releases phase 2 and 3 clinical research findings on ABL001 for biliary tract cancer - ๋๋ฐ์ด์ค
2024-08-13 07:00
Incheon Global Campus Achieves 94.1% Enrollment in Phase 1, Accelerates Recruitment of New Universities - ๊ฒฝ์ธ๋ฐฉ์ก
2024-05-13 07:00
HLB 'Rivoceranib' shows excellent efficacy in breast cancer, with global phase 3 prospects presented - ๋๋ฐ์ด์ค
2024-09-10 01:56
ํฌ์ค์ฝ, ์ ๋ฝ ํ์ดํผ๋ฃจํ ์ํ๋
ธ์ ์ ์ ์ฉ ๊ฐ์ฌ ๊ณต๊ธ - ๋
ธ์ปท๋ด์ค
2024-02-19 08:00
Neurophth Announces Completion of Patient Enrollment for Opvikaยฎ Phase I/II Clinical Trial in the U.S. - ํ๋ด์ค
2024-09-10 07:00
ํฌ์ค์ฝ, ์ ๋ฝ์ ํ์ดํผ๋ฃจํ ์ํ ๋
ธ์ ์ค๊ณต์ ์ ์ฉ ๊ฐ์ฌ ๊ณต๊ธ - MSN
2024-06-19 07:00
Kangstem Biotech Targets FutureStem-AD Approval by 2025 - ํํธ๋ด์ค
2024-03-20 07:00
Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia - ํ๋ด์ค
2024-02-18 08:00
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor - ํ๋ด์ค
2024-03-11 07:00
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer - ํ๋ด์ค
2024-01-02 08:00
Aribio Completes European Phase 3 clinical trials Alzheimer's Disorder Treatment AR1001 - ํฌ์ค๊ฒฝํฅ
2024-06-09 07:00
์ด์ค์ผ ๊ฒฝํฌ์ฌ์ด๋ฒ๋ ๊ต์ํ, NIST โSBIR Phase ์ฌ์ด๋ฒ ๋ณด์ ์ฐ๊ตฌ์โ ์์ - ๋ฉํธ๋ก์ ๋ฌธ-์ค์ฐ์ธต๊ณผ ์๋ฏผ์ ์ํ ์์ฐฌ ์ ๋ณด
2024-02-26 08:00
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024) - ํ๋ด์ค
2024-02-05 08:00
Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia - ํ๋ด์ค
2023-12-12 08:00
Qilu Pharmaceutical Announces Results from Phase I Clinical Study for Its Novel Bispecific Antibody QLS31905 at ESMO Immuno-Oncology Congress - ํ๋ด์ค
2024-05-08 07:00
Hanmi Pharmaceutical's next-generation obesity treatment 'triple agent' was approved by US FDA for phase 1 clinical trial - ๋๋ฐ์ด์ค
2024-06-28 07:00
POSCO International to Jointly Invest 926.3 Billion KRW in Myanmar Gas Field Phase 4 Development - ๋ฉ๋์ปฌํฌ๋ฐ์ด
2023-12-20 08:00
Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Patient Dosed in Phase โ
ข Clinical Study of LNK01001 - ํ๋ด์ค
2024-05-22 05:13
์ํ ๋งค๊ฑฐ์ง Vol.3 ๋ฐํ - ๋ธ๋ฐ์น
2024-02-27 08:00
[์ด๋ก] ์ฌ๋ฃ ๋ด ๋ณตํฉ์๊ท ์ ์ฒจ๊ฐ๊ฐ ์ด์ ์๋์ ์ฌ์์ฑ์ , ์์์ ์ํ์จ, ํ์ก์ฑ์, ๋ถ๋ด ์ ํด๊ฐ์ค ๋ฐ ๋ถ ์ค ๋ฏธ์๋ฌผ์ ๋ฏธ์น๋ ์ํฅ - ์๋์ ๋ฌธ ์จ๋ผ์ธ ๋ฏธ๋์ด, ๋ผ์ง์ ์ฌ๋
2024-01-09 08:00
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform - ํ๋ด์ค
2023-12-05 08:00
Ascletis Announces Initiation of Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne - ํ๋ด์ค
2024-07-22 08:28
Hypontech Listed Among Global Top 9 Single-Phase Inverter Suppliers by Wood Mackenzie - ํ๊ตญ์ฌํ๋ณต์ง์ ๋
2023-10-20 07:00
2023 PWS: Phase 2 ๊ทธ๋๋ ํ์ด๋ ์ด๋ฒคํธ ์๋ด - pubgesports.com
2024-04-11 07:00
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study - ํ๋ด์ค
2023-12-05 08:00
J INTS BIO Gives Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, at ESMO Asia 2023 - ํ๋ด์ค
2024-02-05 08:00
Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders - ๋ด์ค์์ด์ด
2024-01-18 08:00
LG Chem's Aveo Oncology Initiates U.S. Phase III Trial for Ficlatuzumab in Head and Neck Cancer - Korea IT Times
2023-12-06 08:00
[์ค๋ช
ํ ๊ฒฝํฅ] COP28์์ ํ์์ฐ๋ฃ โํด์ถโ๊ณผ โ๊ฐ์ถโ, ๋ญ๊ฐ ๋ค๋ฅธ๋ฐ? - ๊ฒฝํฅ์ ๋ฌธ
2023-12-06 08:00
Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment - ํ๋ด์ค
2023-12-16 08:00
Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction - ํ๋ด์ค
2023-10-24 07:00
ํ๋์์ง๋์ด๋งยทํ๋๊ฑด์ค JV, ์ฌ์ฐ๋ ์ํธ๋ผ ๊ฐ์ค์ฒ๋ฆฌ์์ค(Phaseโ2) ์์ฃผ - ํ๋์๋์ฐจ๊ทธ๋ฃน
2024-04-17 07:00
[WIS 2024]GRC, 1์(single-phase) ์ก์นจ๋๊ฐ ์๋ฃจ์
์ ๋ณด์ฌ - ZUM ๋ด์ค
2023-11-21 08:00
Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection - ํ๋ด์ค
2023-12-20 08:00
HD Hyundai Completes Phase 1 of FOS Project... Establishing a Visible Shipyard - IT์กฐ์
2023-12-01 08:00
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS - ํ๋ด์ค
2023-11-30 08:00
ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study - ํ๋ด์ค
2023-11-15 08:00
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology - ํ๋ด์ค
2023-11-29 08:00
Close to Best in Class: Immunovant Achieves Phase 1 Success with IMVT-1402" 600mg - ๋๋ฐ์ด์ค
2024-01-08 08:00
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) - ํ๋ด์ค
2024-06-10 05:56
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study - ํ๊ตญ์ฌํ๋ณต์ง์ ๋
2023-12-06 08:00
์์ธ์๋ฆฝ๋ ์ต์งํฌ ๊ต์-์ด์ฃผํ ๊ต์ ์ฐ๊ตฌํ, ๋งฅ์ (Mxene)์ ์ ๊ตฌ์ฒด์ธ MAX phase ๋ฌผ์ง์ ์์ ํ ์ค๊ณ ๊ฐ๋ฅ์ฑ ์ ์ - ํ๊ฒจ๋
2023-12-21 08:00
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial - ํ๋ด์ค
2023-10-23 07:00
Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington's Disease - ํ๋ด์ค
2023-10-10 07:00
2023 PWS: Phase 2 ํฐ์ผํ
์๋ด - ๋ด์ค - pubgesports.com
2024-07-24 07:00
HYBE Appoints Lee Jaesang as New CEO, Leading Next Phase of Growth - ํ๊ตญ์์ด๋ท์ปด
2023-10-24 07:00
ํ๋์์ง๋์ด๋งยทํ๋๊ฑด์ค JV, ์ฌ์ฐ๋ ์ํธ๋ผ ๊ฐ์ค์ฒ๋ฆฌ์์ค(Phase-2) ์์ฃผ - ํผ๋ธ๋ฆญ๋ด์ค
2023-10-11 07:00
Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China - ํ๋ด์ค
2024-01-15 08:00
๋ ํผ๋ฐ์ค ์์นญ์ ๊ผญ ํ์ํ 5๊ฐ์ง+ ๋ฌด๋ฃ ์ฌ์ฉ ์ฝ๋ - ๋ธ๋ฐ์น
2023-11-07 08:00
ํ๋๊ฑด์คยทํ๋์์ง๋์ด๋ง, ์ฌ์ฐ๋ ์ํธ๋ผ ๊ฐ์ค์ฒ๋ฆฌ์์ค(Phase-2) ์์ฃผ - ๋ถ๋์ฐ์ ๋ฌธ
2023-10-24 07:00
ํ๋์์ง๋์ด๋งยทํ๋๊ฑด์ค JV, ์ฌ์ฐ๋ ์ํธ๋ผ ๊ฐ์ค์ฒ๋ฆฌ์์ค(Phase-2) ์์ฃผ - ์ด๋ฆฐ๋ด์คํต์
phase์น์ฌ์ดํธ์ ๋ํ ์ถ๊ฐ ์ ๋ณด
์ฝ phase
Warning : file_get_contents(aCache/search/kr/ phase): Failed to open stream: Permission denied in
/var/www/hoodb/function.php on line
340
Back to Top
ํฉ์ธ๋ฒ
|
๋ ๋ฒ์ฟ ์
|
๋ฆฐํจํํฌ
|
๋์ค๋ฅ
|
์ผ์ฑ์นด๋
|
์ฃผํ์
|
๋์ฑ
|
์๋ฏผํ
|
์ถ๊ตฌ
|
Chat GPT
|
์ ๋ฏผ์
|
KT ์ธํฐ๋ท
|
LCK ๊ฒฐ์น
|
์ํธ์
|
ํฌ๋ํํค
|
์์คํธ๋ก๋ด
|
์ ํด๋ฆฌ
|
์์ดํฐ16
|
์๋ฆญ์
|
์ดํด์ธ
|
์์ธ์ ๋ด
|
์ด์์
|
์ํด๋ณด๊ธฐ ์ซ์ด์
|
๊น์์ง
|
๋กฏ๋ฐ์์ด์ธ์ธ
|
์ ์์ฃผ
|
๋ฎํจ
|
NCT ํ์ผ
|
์ฝ์คํผ
|
๋ฅด์ธ๋ผํ
|
๊นํฌ์
|
๋ฐ๋ฅด์
๋ก๋
|
๋ฆฐ๊ฐ๋
|
ํด๋ฆฌ์ค
|
์ ์ ๋ฏธ
|
๊ถ๊ด๋ฏผ
|
์ผ๋ณธ ์ค๊ตญ ์ถ๊ตฌ
|
GPT
|
๋ฐ์์ง
|
๋ง์คํฐ์น
|
๋ฌธ๊ต์
|
๋ณ์ํ
|
์ฝ์คํผ
|
์กฐ๋ณด์
|
๋งจ์
|
์ฐ์จ์ํ
|
์กฐํ
|
์ ์ธ์ด
|
๊น์์ง ์ฌ๊ฒฉ
|
์์ํฌ
|
ํ๋ก์ ํธ KV
|
์ด์ฌ๋ช
|
์ ์ข
์
|
ํผํํฐํผํํฐ
|
๋๊ทธ๋ฐ์ด์ฆ
|
ํจ์์
|
์ค๋ง ๋ ํ๊ตญ
|
์ค์ธํ
|
์ํ
|
์ค์์์ค
|
์ฐ์ํ
|
๋๊ฒฝ์
|
์๋น๋์ ์ฃผ๊ฐ
|
์ค์ธ์
|
์ฅ๊ทผ์
|
์ ์ข
์
|
์ ๊ตญ
|
๋ฒ์ฃ๋์3
|
GPT-o1
|
LCK
|
๋งจ์ ๋ ๋ฆฌ๋ฒํ
|
์ธ๋ฒํํผ
|
ํ๋ฃจ์ธ๋ฒ ์คํธ ๋ํ
|
ํ์๋
ธ๋ฅดํธ
|
KBS
|
ํ๋์์ฉ์
|
ํ๋ผ์ฐ
|
์ฃผ์ฐ์ฌ
|
๊น๊ฐํจ
|
์์ฌ์
|
BJํ์ด
|
์ถ๊ตฌ
|
๋ฐ์ ํ
|
์ฃผ์ฐ์ฌ
|
์ฑ์ผ์ข
|
๊ณ ์น๋ฏผ
|
๋งจ์ ๋ ๋ฆฌ๋ฒํ
|
์ฑํผ์ธ์ค๋ฆฌ๊ทธ
|